Pharmacology and Toxicology for Therapeutics Program (PTTP)
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- 75N95022R00003
- Agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute of Neurological Disorders and Stroke seeks to award multiple indefinite delivery/indefinite quantity contracts to support the Pharmacology and Toxicology for Therapeutics Program. Awardees will conduct all necessary preclinical pharmacology and toxicology testing to inform lead discovery, selection of clinical candidates, and comprehensive studies required for regulatory filings with the FDA. Proposals are due February 25, 2022 and will be evaluated based on technical approach, past performance, and price. Questions regarding the solicitation must be submitted to the government points of contact by February 4, 2022.
There is no set-aside designation. The primary NAICS code is 541715 and PSC code is R425. The total estimated value of all contracts is $174.47 million over ten years to be performed at contractor facilities. Individual task orders will be issued for studies such as single dose PK assessments in rodents and non-rodents, dose range finding toxicity evaluations, and IND package studies required to support up to 15 drug development projects annually.
Notice text
The National Institute on Neurological Disorders and Stroke (NINDS) is pursuing the Ramp-On of Multiple Award Indefinite Delivery/Indefinite Quantity (IDIQ) type contracts to assess the pharmacokinetics, toxicology and safety of promising compounds to support their eventual use as therapeutics. Awardees will support the Pharmacology and Toxicology for Therapeutics Program (PTTP) in all preclinical pharmacology and toxicology testing needed to inform lead discovery and the selection of a clinical candidate. Awardees will also support the NINDS in all comprehensive studies needed for regulatory filings such as FDA Investigational New Drug (IND) applications to allow for clinical evaluation of the candidates.
If you are interested in this opportunity and wish to be considered for award, please review all attachments and submit all requested information and documentation. If you have questions regarding any of the contents of this Request for Proposals (RFP), please reach out to the Government's identified points of contact.
Files
Show all 33
Notice history
| Notice | Type | Posted |
|---|---|---|
| Pharmacology and Toxicology for Therapeutics Program (PTTP) | Award Notice | |
| This notice | Solicitation | |
| Pharmacology and Toxicology for Therapeutics Program (PTTP) | Pre-Solicitation |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity